Association between SLC19A1 gene polymorphism and high dose methotrexate toxicity in childhood acute lymphoblastic leukaemia and non Hodgkin malignant lymphoma: introducing a haplotype based approach
This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Barbara Faganel Kotnik
Department of Oncology and Haematology,
University Children’s Hospital,
University Medical Centre LjubljanaLjubljana, Slovenia
Janez Jazbec
Department of Oncology and Haematology,
University Children’s Hospital,
University Medical Centre LjubljanaLjubljana, Slovenia
Petra Bohanec Grabar
Pharmacogenetics Laboratory,
Institute of Biochemistry
Faculty of Medicine,
University of LjubljanaLjubljana, Slovenia
Cristina Rodriguez-Antona
Hereditary Endocrine Cancer Group Human Cancer Genetics Programme,
Spanish National Cancer Research Centre
Madrid, Spain
Vita Dolzan
Pharmacogenetics Laboratory,
Institute of Biochemistry
Faculty of Medicine,
University of LjubljanaLjubljana, Slovenia